Ventyx Biosciences
VTYX
VTYX
125 hedge funds and large institutions have $1.4B invested in Ventyx Biosciences in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
1% less capital invested
Capital invested by funds: $1.41B → $1.4B (-$12.9M)
4.47% less ownership
Funds ownership: 79.74% → 75.27% (-4.5%)
Holders
125
Holding in Top 10
6
Calls
$1.62M
Puts
$98K
Top Buyers
| 1 | +$69.3M | |
| 2 | +$42.1M | |
| 3 | +$36.7M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$33.5M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$25.8M |
Top Sellers
| 1 | -$109M | |
| 2 | -$50.8M | |
| 3 | -$48.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$38.2M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$24.3M |